<code id='A1EF8F27BB'></code><style id='A1EF8F27BB'></style>
    • <acronym id='A1EF8F27BB'></acronym>
      <center id='A1EF8F27BB'><center id='A1EF8F27BB'><tfoot id='A1EF8F27BB'></tfoot></center><abbr id='A1EF8F27BB'><dir id='A1EF8F27BB'><tfoot id='A1EF8F27BB'></tfoot><noframes id='A1EF8F27BB'>

    • <optgroup id='A1EF8F27BB'><strike id='A1EF8F27BB'><sup id='A1EF8F27BB'></sup></strike><code id='A1EF8F27BB'></code></optgroup>
        1. <b id='A1EF8F27BB'><label id='A1EF8F27BB'><select id='A1EF8F27BB'><dt id='A1EF8F27BB'><span id='A1EF8F27BB'></span></dt></select></label></b><u id='A1EF8F27BB'></u>
          <i id='A1EF8F27BB'><strike id='A1EF8F27BB'><tt id='A1EF8F27BB'><pre id='A1EF8F27BB'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:86956

          Does biotech prepare you for the presidency? Who really wants to gut the FDA? And why do drug companies struggle with IT?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how Vivek Ramaswamy, fresh off his headline-grabbing debut at the first Republican presidential debate, went from a drug industry entrepreneur to a GOP rising star — and how his former biotech colleagues are reacting to it. We also explain the latest news in the life sciences, including a curious data leak and the family business of a famed biotech inventor.

          advertisement

          For more on what we cover, here’s more on Ramaswamy; here’s the news on the data leak; here’s the story on the latest Langer venture; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          Wikipedia

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Anthos stroke drug appears safer than common blood thinner
          Anthos stroke drug appears safer than common blood thinner

          AdobePHILADELPHIA—Aninvestigationaldrugaimedatpreventingstrokessignificantlyreducedtheriskofbleeding

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          Readout LOUD podcast: A CRISPR milestone, biotech mixology

          Whopolicesalgorithms?HowwouldyounamethefirstapprovedCRISPRmedicine?Andwhatpairswellwithabiotechdownt